LOUISVILLE, Ky., Oct. 25, 2025 /PRNewswire/ — MOVA, a leading global smart technology brand, made its debut at Equip Exposition 2025, unveiling its latest smart outdoor solutions. The showcase featured the new LiDAX Ultra Series robotic lawn mowers, the Unified 60V Battery Garden Tools, and the EvoLife Series Power Tools.

As MOVA’s core product line, the LiDAX Ultra Series robotic lawn mowers took center stage at Equip Exposition 2025, featuring the latest UltraView™ 2.0 navigation system that combines 3D LiDAR and Vision for seamless, out-of-the-box performance. The model is available in two size options — 0.25 and 0.5 acres — and offers dual-map automatic mapping, slope handling up to 45%, and fully adjustable cutting heights from 3 to 10 cm, delivering precise, effortless lawn care.

MOVA also unveiled its new 60V Brushless Garden Tool Series, bringing smart control, strong performance, and easy handling to modern yard care. Each tool in the series connects to the MOVA App with IoT compatibility and OTA upgrades, enabling real-time tracking and continuous software optimization. All tools share the MOVA 60V battery platform with an ultra-fast charger, reaching full power in about 30 minutes for efficient, continuous operation.

Eight SKUs were brought to the show. The highlights include the MOVA Self-Propelled Lawn Mower, featuring PaceMate™ Self-Propelling technology that adjusts its pace according to the user’s gripping pressure. It’s also equipped with the TurboFlow™ system that supports high-performance mulching, bagging, and rear discharge, making it effortless to tackle dense and tall grass; the MOVA String Trimmer, featuring the EquiDrive™ centered-motor and InstaLoad™ design, delivers exceptional balance and allows users to reload the trimming line with a single touch.

Additionally, the EvoLife Series Power Tools made their debut, featuring 14 compact, stylish, and lightweight designs powered by lithium batteries and a unified Type-C “one-cable” charging platform.

Short for “Evolution of Life,” EvoLife embodies the concept of “Tools Without Boundaries,” expanding beyond traditional DIY into modern lifestyles. Centered around four key areas—Tools, Automotive, Outdoor, and Health—the series is designed to deliver intelligent convenience to everyday life.

Highlights include the MOVA Electric Precision Screwdriver, featuring 86 magnetic bits that handle a wide range of fine-repair tasks and nine additional accessories neatly packed in one case for convenient use; and the MOVA Portable Inflator, equipped with a 26 mm cylinder bore delivering up to 150 PSI, five intelligent modes for different applications, and a sunlight-readable display covering 85% of the surface.

To bring these innovations closer to visitors, MOVA’s booths provide perfect environments for product demonstration. While the indoor booth showcased detailed product displays, the outdoor booth recreated a realistic garden setting with cypress trees, real logs, and turf, giving visitors opportunities to test the tools hands-on and experience their performance in real-life conditions.

MOVA’s presence at Equip Exposition 2025 underscores its determination to expand into categories of yard tech and smart tools, and create smarter, more efficient experiences for users worldwide.

The product portfolio presented at the exhibition is expected to be launched in the spring of 2026. For more information, please visit: https://www.mova.tech/ 

About MOVA

MOVA, a leading global smart technology brand, integrates advanced AI, robotics, and design innovation to create intelligent living solutions for both indoor and outdoor scenarios. The brand continues to explore how technology empowers home life, enabling users to free their hands and focus on their passions.

With the 4G LTE Function, the LAMTTO DC22 allows you to keep your vehicle safe with real-time disturbance notifications, Live View, and GPS location anytime on your phone.

NEW YORK, Oct. 25, 2025 /PRNewswire/ — LAMTTO has introduced the new LAMTTO DC22 dash cam. This 4G LTE model transcends the limitations of traditional dash cams, integrating radar alerts, remote monitoring and voice chat, and GPS tracking, offering numerous vehicle-related benefits. It’s ideal for frequent travelers, urban commuters, rideshare drivers, fleet managers, parents of teenagers, and anyone concerned with vehicle safety.

Because the LAMTTO DC22 supports 4G LTE cellular networks, it enables real-time remote monitoring. The “UBoxPro” smartphone app allows users to easily access live images, playback videos, conduct remote two-way conversations, and track the vehicle’s location anytime, anywhere. Even from home or the office, you can always check the vehicle’s status.

This always-on, real-time remote monitoring system also supports an intelligent radar alert system. When the built-in G-sensor and radar detect a collision or motion, the system immediately starts recording and sends a remote notification to the user’s phone via 4G. Video footage is also automatically backed up to the cloud. Upon receiving an alert, users can instantly access the video and establish two-way audio communication with the dashcam through the app. This allows for a quick response, even if your vehicle suffers scratches or damage in areas you can’t see.

The security camera for car also features integrated GPS tracking, recording the vehicle’s location in real time and allowing it to be viewed remotely via the app. This is particularly useful for parents monitoring novice drivers or business owners managing fleet efficiency.

The LAMTTO DC22 LTE dashcam also prioritizes the driving experience. Equipped with dual cameras, the DC22 boasts a 105° wide-angle front lens and a 140° ultra-wide-angle interior lens. It provides comprehensive blind spot monitoring, including four infrared lights and WDR technology, for clear video capture day and night. Powered by an OBD-II port, it provides continuous parking monitoring even when the engine is off.

DC22 4G Dash Camera offers numerous benefits for every driver: rideshare drivers can store trip videos and monitor the vehicle’s interior; passengers can view parked vehicles; fleet managers can receive alerts about aggressive driving and access relevant video and location information; and parents can feel more confident letting their children drive.

The LAMTTO DC22 cellular dash cam boasts a compact design that blends seamlessly with any vehicle interior. It operates flawlessly in all weather conditions.

Each LAMTTO DC22 kit includes everything the driver needs for installation: a 4G LTE dash cam, OBD power cable, a SIM card, a memory card, installation tools, electrostatic sticker and a user manual.

The new DC22 4G LTE dash cam is now available through the LAMTTO website and Amazon.

For more information, technical specifications, and product images, please visit the official product page on the LAMTTO website.

About LAMTTO

LAMTTO was founded in 2014. Our main products are CarPlay smart screens and dashcams. We are constantly exploring automotive technology, hoping that every driver can enjoy the benefits of modern technology without having to replace their beloved vehicle. We are LAMTTO, a brand dedicated to revitalizing classic vehicles.

For more information, please visit https://lamtto.com/ or Contact us : support@lamtto.com

BANDUNG, Indonesia, Oct. 25, 2025 /PRNewswire/ — Through PT Bio Farma (Persero), Indonesia has played a strategic and sustained role in the Developing Countries Vaccine Manufacturers’ Network (DCVMN), working to ensure equitable access to safe, high-quality, and affordable vaccines. Since DCVMN’s founding in 2000, Bio Farma has been a key driver in advancing vaccine self-reliance and public health capacity in developing countries.

Collaboration between Bio Farma and DCVMN has been established since the inception of the network. At the first DCVMN Annual General Meeting in Noordwijk in 2000, Bio Farma was one of ten founding members dedicated to advancing vaccine collaboration. In April 2001, Bio Farma in Bandung hosted the 2nd AGM, where the network formalized the DCVMN’s structure and governance. Chaired by then-President Director Thamrin Poeloengan, this meeting established Indonesia as a hub for vaccine collaboration and knowledge-sharing among developing countries.

Shadiq Akasya, current President Director of Bio Farma, stated that the company’s participation in DCVMN reflects Indonesia’s commitment to contributing to global health beyond national interests.

“Bio Farma’s involvement in DCVMN since its establishment is not merely about representation, but about making a tangible contribution toward global vaccine self-reliance. Through collaboration and innovation, we are committed to delivering equitable and sustainable health solutions for all,” said Shadiq.

“We believe that the true strength of the developing countries’ vaccine industry lies in collaboration. Through our active role in DCVMN, we aim to ensure that every nation has access to safe, high-quality, and affordable vaccines, a real manifestation of Indonesia’s contribution to global health security,” he added.

In 2004, Bio Farma, together with other DCVMN members, played a vital role in expanding access to the pentavalent (DPT-HepB-Hib) vaccine through a technology-transfer collaboration with the Netherlands Vaccine Institute. This achievement demonstrated that Bio Farma’s contributions within the DCVMN network are not symbolic but deeply technical and practical.

Global trust in Bio Farma has continued to grow. In 2012, Indonesia once again hosted the 13th DCVMN AGM in Bali. Mahendra Suhardono, one of Bio Farma’s directors at the time, was elected President of the Executive Committee for the 2013 – 2014 term.

Indonesia’s leadership was further recognized when Bio Farma was entrusted to serve as Chair of the Board of DCVMN for the 2023-2025 period, acting as a bridge between network members and global strategic priorities, while showcasing Indonesia’s capacity to lead the vaccine industry in developing countries.

Bio Farma’s commitment to innovation goes far beyond collaboration. In 2020, its nOPV2 vaccine became the first to receive an Emergency Use Listing from the World Health Organization, enabling faster deployment of vaccines during global health emergencies. This achievement reflected not only Bio Farma’s scientific and technical excellence but also effective coordination and communication among multiple international stakeholders, including funders, scientists, academic researchers, policymakers, global vaccine advocates, and vaccine manufacturers. Such collaboration enabled the rapid development, approval, and rollout of nOPV2 during a critical moment for global public health.

This milestone demonstrated that a developing-country manufacturer can achieve world-class innovation, meeting the highest international standards of safety, quality, and efficacy recognized by the WHO. Beyond being a scientific breakthrough, nOPV2 represents technological self-reliance and global confidence in Indonesia’s capability to contribute meaningfully to international health security. Bio Farma’s success serves as an inspiration to all DCVMN members to continue strengthening their research, development, and production capacity in pursuit of achieving vaccine self-sufficiency and global health resilience across developing countries.

With a production capacity of more than 3.5 billion doses per year, Bio Farma supplies vaccines to over 150 countries and holds WHO Prequalification certification for 12 types of vaccines. As the Center of Excellence for the Organization of Islamic Cooperation (OIC) in vaccine development, production, and distribution, Bio Farma continues to strengthen Indonesia’s strategic role in the global health landscape.

The upcoming 26th DCVMN Annual General Meeting, to be held in Bali on 29–31 October 2025, marks an important moment for Indonesia to reaffirm its leadership in global health diplomacy. Through this forum, Bio Farma is committed to advancing innovation, collaboration, and vaccine self-reliance worldwide, toward a more resilient and equitable global health ecosystem.

About DCVMN
The Developing Countries Vaccine Manufacturers Network (DCVMN) is a global alliance of 46 vaccine manufacturers from 17 developing countries, established in 2000 to strengthen public health through equitable access to high-quality vaccines.

DCVMN promotes collaboration among its members through advocacy, capacity building, professional training, and joint research initiatives, aimed at enhancing global immunization programs.

Working closely with international organizations such as WHO, UNICEF, GAVI, CEPI, PATH, CHAI, and the Gates Foundation, DCVMN strives to ensure that every nation has the capability to produce and supply affordable, life-saving vaccines. For further information, please visit dcvmn.org.

About Bio Farma
PT Bio Farma (Persero) is Indonesia’s state-owned life science company and the largest vaccine manufacturer in Southeast Asia.

Founded in 1890 and headquartered in Bandung, Bio Farma produces and supplies vaccines to more than 150 countries, while playing an active role in biotechnology research, innovation, and global health security.

As a member of DCVMN, Bio Farma continues to contribute to international collaboration to ensure equitable vaccine access and improved global public health. For further information, please visit www.biofarma.co.id.

Contact Us

PT Bio Farma (Persero)
Corporate Communication

Jl. Pasteur No.28 Bandung,
Jawa Barat Indonesia 40161
Website: www.biofarma.co.id
Email: corcom@biofarma.co.id

DCVMN

Route de Crassier, 7
CH-1262 Nyon
Switzerland
Website: dcvmn.org
Email: info@dcvmn.net

KUALA LUMPUR, Malaysia, Oct. 25, 2025 /PRNewswire/ — Malaysia Healthcare Travel Council (MHTC) concluded a four-day familiarisation visit by senior Royal Oman Police (ROP) officials from 21 to 24 October 2025. The delegation, led by Brigadier Dr Naseer Al-Manthery, Director General of Medical Services for Security Services, visited leading Malaysian hospitals and patient facilitation centres to evaluate clinical capabilities and care coordination systems.

The visit builds on government-to-government engagement between MHTC and ROP that began in January 2025, when both organisations first discussed structured healthcare collaboration to address the medical needs of Omani security personnel and their families. This familiarisation programme represents the next phase of that partnership, providing ROP leadership with direct assessment of Malaysian healthcare infrastructure and international patient services.

The programme included familiarisation visits to KPJ Damansara Specialist Hospital 2, Prince Court Medical Centre, PERKESO Rehabilitation Centre Tun Abdul Razak (Melaka), and Sunway Medical Centre. During these visits, ROP officers met with hospital leadership to discuss referral pathways, international patient services, and areas of collaboration in clinical training, fellowship opportunities, and doctor exchange programmes. These initiatives aim to strengthen professional development and medical expertise between Malaysia and Oman, fostering long-term partnerships in healthcare excellence. The visit concluded with a networking dinner hosted by His Excellency Sheikh Alabbas Bin Ibrahim Alharthi, Ambassador of the Sultanate of Oman to Malaysia.

“Malaysia’s healthcare system delivers clinical excellence with efficient patient facilitation and care coordination,” said Suriaghandi Suppiah, Chief Executive Officer of MHTC. “This visit demonstrates our readiness to support Omani patients and strengthens our government-to-government cooperation. Since our initial engagement with ROP in January, we have worked to create practical pathways for Omani security personnel to access Malaysian healthcare services.”

“This visit has given us direct insight into Malaysia’s healthcare capabilities and patient coordination systems. The clinical expertise we observed at these hospitals, combined with the structured approach to international patient care, confirms Malaysia’s capacity to support our medical needs. We look forward to strengthening this partnership and establishing clear referral pathways for our personnel and their families,” said Brigadier Dr Naseer Al-Manthery, Director General of Medical Services for Security Services, Royal Oman Police.

The visit precedes Malaysia Healthcare Week in Oman, scheduled from 29 October to 5 November 2025, where MHTC will promote Malaysian healthcare services to Omani patients and stakeholders. MHTC remains committed to serving as a comprehensive one-stop centre for international patient referrals, coordinating seamless access to Malaysia’s network of MHTC member hospitals and specialised medical services. This commitment forms a core pillar of the Malaysia Year of Medical Tourism (MYMT) 2026 campaign, which will showcase Malaysia’s integrated approach to international patient care and strengthen the nation’s position as a premier global healthcare destination.

For media inquiries and further information, please contact:

Mohamad Shahizam Fauzi
Head, Communications
+603 8776 6168                    
shahizam.f@mhtc.org.my

Siti Hamidah Mohd Najib                                                      
Senior Executive, Communications
+603 8776 6168        
hamidah.m@mhtc.org.my

About Malaysia Healthcare Travel Council

Malaysia Healthcare Travel Council (MHTC), established in 2009 under the purview of the Ministry of Health (MOH) Malaysia, is entrusted with developing and nurturing the “Malaysia Healthcare” brand. MHTC enhances, coordinates, and promotes Malaysia’s healthcare travel industry by fostering industry collaborations and building valuable public-private partnerships both domestically and internationally. With 80 member hospitals nationwide, MHTC continues to elevate the healthcare travel ecosystem through strong branding, seamless patient experiences, and strategic market initiatives. In line with these efforts, MHTC is spearheading the Malaysia Year of Medical Tourism (MYMT) 2026, the nation’s first dedicated year to celebrate and advance healthcare travel. MYMT 2026 serves as a milestone initiative to showcase Malaysia’s world-class healthcare offerings, strengthen its position as the premier global healthcare destination, and highlight the industry’s significant contribution to the national economy.

More information can be found at https://www.mhtc.org.my/. 

SAN JOSÉ, Costa Rica , Oct. 25, 2025 /PRNewswire/ — openvela’s first Global Developer Conference has wrapped up successfully, marking a pivotal milestone in the open-source AIoT ecosystem.

openvela is an open-source AIoT operating system built by Xiaomi based on NuttX, under the Apache 2.0 license. As the largest contributor to the NuttX community, Xiaomi has been making continuous contributions to the NuttX community since 2017, accounting for over 50% of code submissions. It played a key role in promoting NuttX to become an Apache top-level project in 2022.

Gregory Nutt expressed enthusiastic endorsement for the partnership: “I’m delighted openvela has adopted NuttX. It’s a win-win that makes openvela a stronger platform while advancing NuttX’s development.” NuttX’s 15-year-old industrial-grade stable technology provides a solid foundation for openvela.

openvela, a tailored open-source operating system for the AIoT sector, deeply aligns with the diverse scenario requirements of IoT devices and AI hardware. Across multiple domains such as smart watches, fitness trackers, smart wearables, AI glasses, smart speakers, headphones, and smart home appliances, it has emerged as the preferred choice for developers and enterprises worldwide.

openvela is the open-source version of Xiaomi Vela, an internal operating system developed by Xiaomi. It features an excellent kernel and integrates comprehensive system services including cross-device interconnection, lightweight aesthetics, multimedia, security protection, edge-side AI, lightweight application framework, and diagnostic & testing tools. Designed specifically for IoT devices and AI hardware, this lightweight OS has been widely adopted and rigorously validated across 100 million-level terminal devices. Leveraging the open nature of its open-source ecosystem, it provides a highly efficient and accessible innovation platform for researchers and developers around the globe. By offering low-entry and high-yield R&D support, it helps development teams overcome efficiency bottlenecks in technology implementation, significantly shortening the entire process cycle from concept validation to mass production and delivery, and accelerating the commercialization of AIoT innovations.

Rooted in profound industry insights and technical expertise, openvela continues to lower the barrier to innovation in the AIoT space, fostering collaborative development across the entire industrial chain. It has become a core driving force behind the prosperity of the ecosystem and technological advancements in the field.